San Francisco, California
London, United Kingdom
Can stem cells deliver on their promise for Parkinson’s?
Stem cells have been touted as the next big thing in the quest for better therapies to slow and even reverse the progress of Parkinson’s since the 1990s – but have so far remained tantalisingly out of reach.
Roger Barker is Professor of Clinical Neuroscience at the University of Cambridge and an Honorary Consultant Neurologist at Addenbrooke's Hospital in Cambridge.
A world leading expert in Parkinson's, Roger is involved in clinical trials of cell and gene therapies, giving him a unique perspective into the most promising treatments currently being developed and tested for Parkinson's.
Roger's talk will cover: - why cell therapies hold so much potential for Parkinson's - the work that is being undertaken internationally - the key challenges that need to be tackled to make cell therapies a reality
Roger will talk specifically about his work leading a team of researchers from across Europe in the TRANSEURO trial (funded by a €12 million grant from the European Commission) that aims to show that transplanting healthy cells into the brain can be a safe and effective treatment for Parkinson's and how this is leading to the next generation of stem cell based trials in Parkinson's. May 2015 marked an important milestone in the research as the first person with Parkinson’s in the UK received a cell transplant.
When & Where
We're the Parkinson's support and research charity. For more than 40 years we've been working to find a cure and improve life for everyone affected by Parkinson's.